Search Results Search Sort by RelevanceMost Recent Viewpoint May 2022 Reimagining Roles of Dietary Supplements in Psychiatric Care Katherine Wu, MD and Erik Messamore, MD, PhD Government-supported review and safety monitoring is needed for dietary supplements’ use in the care of patients with mental illness. AMA J Ethics. 2022;24(5):E437-442. doi: 10.1001/amajethics.2022.437. Podcast May 2022 Author Interview: “Reimagining Roles of Dietary Supplements in Psychiatric Care” Dr Katherine Wu joins Ethics Talk to discuss her article, coauthored with Dr Erik Messamore: “Reimagining Roles of Dietary Supplements in Psychiatric Care.” Case and Commentary Jun 2006 Prescribing Placebos Perry G. Fine, MD Virtual Mentor. 2006;8(6):377-380. doi: 10.1001/virtualmentor.2006.8.6.ccas4-0606. In the Literature Oct 2004 Some Ethical Concerns about Placebo Operations Luke P. Brewster, MD Virtual Mentor. 2004;6(10):443-445. doi: 10.1001/virtualmentor.2004.6.10.jdsc1-0410. Medicine and Society Oct 2023 What Might Aducanumab Teach Us About Clinicians’ Judgment About Whether to Recommend Emerging Alzheimer’s Interventions? Adam W. Burroughs, MD and Lewis P. Krain, MD Ethics questions about care of patients with AD could influence clinicians’ judgment about whether and when to recommend aducanumab. AMA J Ethics. 2023;25(10):E777-782. doi: 10.1001/amajethics.2023.777. In the Literature Jul 2001 Clinical Use of Placebo Keith Bauer, PhD, MSW Virtual Mentor. 2001;3(7):226-227. doi: 10.1001/virtualmentor.2001.3.7.jdsc1-0107. Case and Commentary Nov 2010 The Ethics of Diagnosing Nonepileptic Seizures with Placebo Infusion James L. Bernat, MD Virtual Mentor. 2010;12(11):854-859. doi: 10.1001/virtualmentor.2010.12.11.ccas3-1011 AMA Code Says Nov 2010 AMA Code of Medical Ethics’ Opinions on Using Drugs and Surgery for Purposes Other than Treatment AMA Council on Ethical and Judicial Affairs Virtual Mentor. 2010;12(11):860-863. doi: 10.1001/virtualmentor.2010.12.11.coet1-1011.
Viewpoint May 2022 Reimagining Roles of Dietary Supplements in Psychiatric Care Katherine Wu, MD and Erik Messamore, MD, PhD Government-supported review and safety monitoring is needed for dietary supplements’ use in the care of patients with mental illness. AMA J Ethics. 2022;24(5):E437-442. doi: 10.1001/amajethics.2022.437.
Podcast May 2022 Author Interview: “Reimagining Roles of Dietary Supplements in Psychiatric Care” Dr Katherine Wu joins Ethics Talk to discuss her article, coauthored with Dr Erik Messamore: “Reimagining Roles of Dietary Supplements in Psychiatric Care.”
Case and Commentary Jun 2006 Prescribing Placebos Perry G. Fine, MD Virtual Mentor. 2006;8(6):377-380. doi: 10.1001/virtualmentor.2006.8.6.ccas4-0606.
In the Literature Oct 2004 Some Ethical Concerns about Placebo Operations Luke P. Brewster, MD Virtual Mentor. 2004;6(10):443-445. doi: 10.1001/virtualmentor.2004.6.10.jdsc1-0410.
Medicine and Society Oct 2023 What Might Aducanumab Teach Us About Clinicians’ Judgment About Whether to Recommend Emerging Alzheimer’s Interventions? Adam W. Burroughs, MD and Lewis P. Krain, MD Ethics questions about care of patients with AD could influence clinicians’ judgment about whether and when to recommend aducanumab. AMA J Ethics. 2023;25(10):E777-782. doi: 10.1001/amajethics.2023.777.
In the Literature Jul 2001 Clinical Use of Placebo Keith Bauer, PhD, MSW Virtual Mentor. 2001;3(7):226-227. doi: 10.1001/virtualmentor.2001.3.7.jdsc1-0107.
Case and Commentary Nov 2010 The Ethics of Diagnosing Nonepileptic Seizures with Placebo Infusion James L. Bernat, MD Virtual Mentor. 2010;12(11):854-859. doi: 10.1001/virtualmentor.2010.12.11.ccas3-1011
AMA Code Says Nov 2010 AMA Code of Medical Ethics’ Opinions on Using Drugs and Surgery for Purposes Other than Treatment AMA Council on Ethical and Judicial Affairs Virtual Mentor. 2010;12(11):860-863. doi: 10.1001/virtualmentor.2010.12.11.coet1-1011.